The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.90
Bid: 17.92
Ask: 18.00
Change: -0.50 (-2.72%)
Spread: 0.08 (0.446%)
Open: 18.20
High: 18.20
Low: 17.90
Prev. Close: 18.40
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First Day of Dealings on the Main Market

1 May 2015 08:00

RNS Number : 9426L
Nanoco Group PLC
01 May 2015
 

 

For immediate release

1 May 2015

 

 

 

NANOCO GROUP PLC

("Nanoco" or the "Company")

 

First Day of Dealings on the Main Market

and Completion of Placing to raise £20 million gross

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, is pleased to announce the commencement of trading in its ordinary shares at 8.00am today on the Main Market of the London Stock Exchange and admission to the premium segment of the Official List of the UK Listing Authority. The commencement of trading on the Main Market is simultaneous with the cancellation of the Company's shares on AIM.

 

The commencement of trading on the Main Market is the final condition for the completion of the Placing, initially announced on 31 March 2015, of 19,047,619 new ordinary shares at a price of 105 pence each, raising gross proceeds of £20 million.

 

Highlights

 

· The net proceeds of the Placing of £18.65 million will enable Nanoco to fund its Business Expansion Strategy of accelerated research, development and commercialisation in its four key target markets - electronic display, LED lighting, solar power and biological imaging.

 

· Use of the proceeds are planned to include:

 

- Improved working capital to support increased capacity and continued optimisation of Nanoco's CFQD® quantum dot production processes

 

- Hiring additional research and development staff and enhancing the senior management structure to re-organise the business into four distinct business divisions, reflecting the key target markets

 

- Broadening the Company's research capabilities in solar through the appointment of a specialist solar panel manufacturer to prove Nanoco's technology on larger solar panels

 

- Investment in laboratory space and the enhancement of the Company's intellectual property portfolio

 

· The transition from AIM to the Main Market is expected to provide a more appropriate platform for the continued growth of the business, raise its profile and improve the trading liquidity of the Company's shares

 

· As previously announced, Robin Williams, a Non-executive Director of Nanoco, through his SIPP, subscribed for 9,523 ordinary shares in the Placing at 105 pence per share. Therefore, on Admission, Robin is interested in of 9,532 ordinary shares, representing to 0.004% of the enlarged issued share capital of the Company

 

Michael Edelman, Nanoco's Chief Executive Officer, commented: "Nanoco's transition from AIM to the Main Market comes at an exciting point in the Company's development and marks an important step in the Company's evolution towards its goal of becoming a leading, global materials science business.

 

"I would like to thank the new and existing investors who subscribed for shares in the Placing which accompanied our move to the Main Market. The proceeds from the Placing will allow us to accelerate the commercialisation of our technology through the funding of further R&D and through the formation of four distinct business divisions focused on our key target markets of electronic display, LED lighting, solar power and biological imaging.

 

"We are very excited by our commercial progress in the display market. We expect, the first LCD TVs to incorporate our technology to be launched in the near future and our worldwide licensing partner Dow is close to commissioning its mass production plant in South Korea, where Nanoco quantum dots will be manufactured in much larger quantities."

 

Total voting rights

 

The total number of ordinary shares in the Company immediately following admission, including the New Ordinary Shares, is 236,378,002 each with equal voting rights. This total voting rights figure can be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in the Company under the Disclosure and Transparency Rules of the Financial Conduct Authority.

 

 

All capitalised terms in this announcement have the meaning given to them in the Circular posted to shareholders on 31 March 2015. The Circular, and the Prospectus, are available at the investor relations section of Nanoco's website, www.nanocotechnologies.com.

 

 

For further information, please contact:

 

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

 

Mark Sullivan, Interim Chief Financial Officer

 

 

 

Canaccord Genuity - Sponsor and Joint Broker

Tel: +44 (0) 20 7523 8000

Simon Bridges

 

Cameron Duncan

Mark Whitmore

 

 

 

Liberum - Joint Broker

Tel: +44 (0) 20 3100 2000

Simon Atkinson

 

Richard Bootle

 

 

 

Buchanan

Tel: +44 (0) 20 7466 5000

Mark Court / Sophie Cowles / Stephanie Watson

 

 

 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nanomaterials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, it has an exclusive manufacturing and marketing licensing agreement with The Dow Chemical Company.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.

 

Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocotechnologies.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBRGDSDXXBGUG
Date   Source Headline
9th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Apr 20244:06 pmRNSTR-1: Notification of Major Holdings
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20243:02 pmRNSExercise of Deferred Bonus Options
18th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Apr 20241:56 pmRNSNotification of Major Holdings
17th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Apr 20244:10 pmRNSDirector/PDMR Shareholding
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Apr 20247:00 amRNSResult of Tender Offer
28th Mar 202412:52 pmRNSGeneral Meeting - Voting Results
27th Mar 20247:00 amRNSInterim Results
11th Mar 202412:47 pmRNSPosting of Circular
11th Mar 20247:00 amRNSProposed return of up to £33.0 million
8th Feb 20247:00 amRNSHalf Year Trading Update
7th Feb 202411:23 amRNSDirector Declaration
24th Jan 20247:00 amRNSReceipt of Final Litigation Proceeds
23rd Jan 20244:02 pmRNSNotification Of Transactions By PDMR
16th Jan 20243:40 pmRNSDirector/PDMR Shareholding
15th Jan 20244:35 pmRNSHolding(s) in Company
12th Jan 20249:45 amRNSJoint Development Agreement with European Customer
22nd Dec 20237:00 amRNSAppointment of Financial Adviser and Joint Broker
21st Dec 202312:00 pmRNSAppointments of Non-Executive Directors
12th Dec 20239:35 amRNSBlocklisting six-monthly return
7th Dec 20233:23 pmRNSResult of AGM
7th Dec 20237:00 amRNSAGM Statement & Trading Update
15th Nov 20237:00 amRNSFirst ever commercial production order
13th Nov 20234:28 pmRNS2023 Annual Report and Notice of AGM
7th Nov 20237:00 amRNSJoint Development Agreement with Asian Customer
2nd Nov 20232:18 pmRNSHolding(s) in Company
17th Oct 20237:00 amRNSUnaudited Preliminary Results
10th Oct 20237:00 amRNSNotice of Results
3rd Oct 20234:32 pmRNSForeign Currency Hedge of Litigation Settlement
14th Aug 20233:58 pmRNSResult of Meeting
8th Aug 20237:00 amRNSTrading Update
7th Aug 20237:00 amRNSGlass Lewis recommends to support Nanoco’s Board
2nd Aug 20237:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.